Vemurafenib-induced toxic epidermal necrolysis: Is it an emerging side-effect of the drug?

J Eur Acad Dermatol Venereol. 2017 Aug;31(8):e354-e355. doi: 10.1111/jdv.14150. Epub 2017 Feb 21.

Authors

S Kılıç¹, E Özkaya¹, C Baykal¹, S Vatansever²

Affiliations

¹ Department of Dermatology and Venereology, Istanbul Medical Faculty, Istanbul University, 34093, Çapa-Istanbul, Turkey.
² Department of Medical Oncology, Institute of Oncology, Istanbul University, 34093, Çapa-Istanbul, Turkey.

PMID: 28150343
DOI: 10.1111/jdv.14150

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Fatal Outcome
Humans
Male
Stevens-Johnson Syndrome / etiology*
Vemurafenib / adverse effects*

Substances

Antineoplastic Agents
Vemurafenib